EUVIMEDEUVIMED entdecken
Crossref

Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission

Manuela Schoeb iD, Paula J C Sintenie, Leontine E H Bakker, Nienke R Biermasz, Femke M van Haalen, Michiel F Nijhoff iD, Friso de Vries, Elizabeth M Winter, Alberto M Pereira iD, Natasha M Appelman-Dijkstra iD

The Journal of Clinical Endocrinology & Metabolism · 15.07.2025 · 110 (8) · e2691-e2699

DOI: 10.1210/clinem/dgae799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 20.11.2024. Verfasst von Manuela Schoeb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bone Quality, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Cushing Syndrome, Bone Density. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: European Calcified Tissue Society, Clinical Research Fellowship and an Exchange in Endocrinology, Grant of the European Union of Medical Specialists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hypercortisolism in endogenous Cushing's syndrome (CS) results in decreased bone mineral density (BMD) and increased fracture risk. Although after remission BMD improves, the fracture rate remains elevated, suggesting that BMD may not adequately reflect fracture risk in this group. The aim was to evaluate bone material properties, another component of bone quality, using impact microindentation in patients with CS in remission.

Methods

Cross-sectional study in 60 CS patients and 60 age-, sex-, and BMD-matched controls at a tertiary referral center between 2019 and 2021. Bone material strength index (BMSi) was measured by impact microindentation using the OsteoProbe® device at the tibia. In addition, laboratory investigation, BMD, and vertebral fracture assessment were performed.

Results

By design, patients and controls were comparable for age (median age 56.5 years), sex (48 women), and BMD at the lumbar spine and femoral neck. They were also comparable regarding the number of fragility fractures (21 vs 27, P = .22). The median time of remission in patients was 6 years (range 1 to 41). Despite comparable BMD, BMSi was significantly lower in CS patients compared to controls (76.2 ± 6.7 vs 80.5 ± 4.9, P < .001). In CS patients, BMSi was negatively correlated with body mass index (r = −0.354, P = .01) but not related to the presence of fracture, physiological hydrocortisone replacement use, other pituitary insufficiencies, or time since remission.

Conclusion

Bone material properties remain altered in patients with endogenous CS, even after long-term remission. These abnormalities, known to be associated with fractures in other populations, may play a role in the persistent bone fragility of steroid excess.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeBone DensityHumansFemaleMaleMiddle AgedCross-Sectional StudiesAdultRemission InductionAgedCase-Control StudiesLumbar VertebraeFemur Neck

Stichwörter der Autor:innen

IMIbone fragilitybone material propertiesbone qualityfracturesimpact microindentationsecondary osteoporosis

Autor:innen und Institutionen

  • Center for Bone Quality, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Center for Endocrine Tumors Leiden, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Department of Endocrinology & Metabolism, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

ORCID-Profile: Manuela Schoeb, Michiel F Nijhoff, Alberto M Pereira, Natasha M Appelman-Dijkstra

Förderung

  • European Calcified Tissue Society
  • Clinical Research Fellowship and an Exchange in Endocrinology
  • Grant of the European Union of Medical Specialists

Zitieren

APA

Schoeb, M., Sintenie, P. J. C., Bakker, L. E. H., Biermasz, N. R., van Haalen, F. M., Nijhoff, M. F., de Vries, F., Winter, E. M., Pereira, A. M., & Appelman-Dijkstra, N. M. (2025). Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission. The Journal of Clinical Endocrinology & Metabolism, 110(8), e2691-e2699. https://doi.org/10.1210/clinem/dgae799

Vancouver

Schoeb M, Sintenie PJC, Bakker LEH, Biermasz NR, van Haalen FM, Nijhoff MF, et al. Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission. The Journal of Clinical Endocrinology & Metabolism. 2025;110(8):e2691-e2699. doi:10.1210/clinem/dgae799

BibTeX
@article{Schoeb2025,
  author = {Schoeb, Manuela and Sintenie, Paula J C and Bakker, Leontine E H and Biermasz, Nienke R and van Haalen, Femke M and Nijhoff, Michiel F and de Vries, Friso and Winter, Elizabeth M and Pereira, Alberto M and Appelman-Dijkstra, Natasha M},
  title = {Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {8},
  pages = {e2691--e2699},
  doi = {10.1210/clinem/dgae799}
}
Kostenlos starten →